<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>In vitro bioaccessibility of lutein diesters in relation to their chemical structure</dc:title><dc:creator>Krstić,	Đurđa	(Avtor)
	</dc:creator><dc:creator>Bolko Seljak,	Katarina	(Avtor)
	</dc:creator><dc:creator>Grilc,	Blaž	(Avtor)
	</dc:creator><dc:creator>German Ilić,	Ilija	(Avtor)
	</dc:creator><dc:creator>Slatnar,	Ana	(Avtor)
	</dc:creator><dc:creator>Albreht,	Alen	(Avtor)
	</dc:creator><dc:subject>lutein diesters</dc:subject><dc:subject>INFOGEST in vitro digestion</dc:subject><dc:subject>bioaccessibility</dc:subject><dc:subject>hydrolysis efficiency</dc:subject><dc:subject>chemical structure</dc:subject><dc:subject>structure-property relationship</dc:subject><dc:description>This study investigated the bioaccessibility of ten synthetic lutein diesters using the in vitro INFOGEST human digestion model, enabling comparative evaluation of their digestive behavior under controlled food-matrix conditions. We revealed that lutein ester chain length was the primary determinant of bioaccessibility, while branching influenced the extent of hydrolysis. Linear short-chain diesters demonstrated superior bioaccessibility (6.7–18.9%). Branched and bulky derivatives, surprisingly, achieved comparable bioaccessibility (6.6–8.3%) despite high hydrolytic resistance, suggesting mechanisms beyond simple ester cleavage. Conversely, long-chain lutein diesters (&gt; C10), prevalent in commercial supplements, exhibited poor micellization, limited hydrolysis, and consequently very low bioaccessibility (&lt;3%). Finally, two pharmaceutical formulations of the lead lutein diester, lutein di(2,2-dimethylpropanoate), were developed: a sunflower oil formulation and a liquisolid formulation utilizing a porous aluminometasilicate carrier. The sunflower oil formulation enabled significantly higher pigment stability and bioaccessibility, highlighting its superior potential for effective lutein delivery in novel food and pharmaceutical applications.</dc:description><dc:date>2026</dc:date><dc:date>2026-03-11 12:03:44</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>180564</dc:identifier><dc:identifier>UDK: 542:616.3-008</dc:identifier><dc:identifier>ISSN pri članku: 1873-7072</dc:identifier><dc:identifier>DOI: 10.1016/j.foodchem.2026.148572</dc:identifier><dc:identifier>COBISS_ID: 271138307</dc:identifier><dc:language>sl</dc:language></metadata>
